Skip to main content

W 447 (Ranitidine Hydrochloride 150 mg)

Pill with imprint W 447 is Orange, Six-sided and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Wockhardt Limited.

Ranitidine is used in the treatment of duodenal ulcer; gerd; cutaneous mastocytosis; duodenal ulcer prophylaxis; erosive esophagitis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W 447

Ranitidine hydrochloride 150 mg W 447

Ranitidine Hydrochloride

W 447
150 mg
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Wockhardt Limited
National Drug Code (NDC)
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, magnesium stearate, silicon dioxide, hypromelloses, titanium dioxide, diethyl phthalate, FD&C Yellow No. 6, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.